Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has submitted a certificate to the stock exchanges as required under SEBI's Depositories and Participants Regulations, 2018. Such certificates are typically submitted periodically to confirm the company's compliance with depositary rules, including reconciliation of its share capital between physical and demat (electronic) forms. This is a routine regulatory filing and does not involve any change in business operations, financials, or shareholding structure. No specific numbers, dates, or financial figures were disclosed in the announcement.
This is a standard compliance filing with no direct effect on the company's earnings, share price, or shareholder value. Investors can treat this as a routine housekeeping update confirming adherence to SEBI's depositary rules.